Geron | GERN - Ebitda

Preço das Ações
1.40
Mudança Diária
-0.01 -0.71%
Mensal
-17.16%
Anual
15.70%
Q2 Previsão
1.36




Ebitda Alterar Data
Amgen USD 5.14B 775M 2025-12
Bio Techne USD 116.71M 13.29M 2026-03
Cassava Sciences USD -11.73M 33.44M 2025-09
Cytokinetics USD -169.32M 19.48M 2026-03
Esperion Therapeutics USD -9.93M 24.99M 2025-09
Exelixis USD 258.29M 15.43M 2026-03
Genmab DKK 186M 291M 2025-12
Geron USD -21.29M 11.82M 2025-12
Gilead Sciences USD 3.02B 1.01B 2025-12
Incyte USD 367.97M 46.53M 2026-03
MacroGenics USD 21.95M 55.39M 2025-09
Novartis USD 5.3B 530M 2026-03
Novavax USD 19.36M 190.79M 2025-12